화상 케어 시장 : 제품 유형별, 화상 심도별, 최종 용도별 - 세계 예측

Global Burn Care Market will exhibit 7.4% CAGR from 2024 to 2032, driven by supportive government policies, funding for burn care research, and public awareness campaigns enhancing access to burn treatment. Government policies and financial backing facilitate advanced research and development in burn treatment technologies, leading to innovative products and therapies. Public awareness campaigns and educational programs funded by governments increase knowledge about burn prevention and the importance of timely treatment. Additionally, government subsidies and funding enhance healthcare infrastructure, ensuring better accessibility to burn care services, especially in underserved areas.

Quoting an instance, In January 2024, MediWound, a biotherapeutics company, secured additional funding of $6.7 million from the US Department of Defense to facilitate its non-surgical burn treatment for the US Army. This boost raises the total budget to $14.4 million, facilitating the development of a temperature-stable version of NexoBrid. MediWound aims to position NexoBrid as the primary non-surgical solution for treating severe burns in pre-hospital environments. This innovative biologic, designed to remove eschar from severe burns, offers a cost-effective alternative to surgical methods, minimizing related costs and complications.

Such initiatives also promote training for medical professionals in burn management, improving patient outcomes and further driving market growth.

The overall burn care market is categorized based on product type, depth of burn, end-use, and region.

The biologics segment will capture a decent market share by 2032, driven by the advanced therapeutic properties and effectiveness of biologics in treating severe burns. Biologics offer innovative solutions for wound healing and tissue regeneration, addressing the limitations of traditional treatments. Their ability to promote rapid and effective recovery, reduce infection risks, and minimize the need for surgical interventions makes them highly sought after. Additionally, ongoing research and development, coupled with increasing awareness and acceptance of biologics, enhance their adoption. Government funding and regulatory support for biologic therapies further propel their market demand, offering advanced, cost-effective solutions for complex burn care challenges.

Clinics could emerge as a prominent end-user across the burn care industry by 2032. Clinics offer specialized, accessible, and patient-centered care, making them ideal for managing burn injuries. Their ability to provide advanced treatments, including wound care and skin grafts, drives their appeal. Increased patient preference for outpatient care, coupled with the rising prevalence of burn injuries, boosts demand for clinic-based services. In addition, technological advancements and improved healthcare infrastructure enable clinics to offer state-of-the-art burn treatments. Cost-effectiveness and the convenience of localized care further contribute to the growing role of clinics in the burn care market.

Asia Pacific burn care market will record a healthy valuation by 2032. Rapid urbanization and industrialization lead to increased burn injuries, driving demand for advanced burn care solutions. Expanding healthcare infrastructure and improving access to medical services enhance the availability of burn treatments. Government initiatives and funding for burn care programs, in line with rising awareness and education about burn prevention and treatment, further support market growth. Additionally, the region's growing focus on modernizing healthcare facilities and adopting innovative technologies contributes to the increased adoption of advanced burn care products and services.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of burns
    • 3.2.1.2 Advancements in burn care technologies
    • 3.2.1.3 Growing awareness and education
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory requirements
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
• 3.6 Technological landscape
• 3.7 Future market trends
• 3.8 Pricing analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Advanced dressing
  • 5.2.1 Alginate dressing
  • 5.2.2 Collagen dressing
  • 5.2.3 Hydrogel dressing
  • 5.2.4 Hydrocolloid dressing
  • 5.2.5 Wound contact layers
  • 5.2.6 Film dressing
  • 5.2.7 Foam dressing
• 5.3 Traditional dressing
• 5.4 Biologics
• 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Depth Of Burn, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Full thickness burns
• 6.3 Partial thickness burns
• 6.4 Minor burns

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Homecare settings
• 7.5 Ambulatory surgical centers (ASCs)
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 3M Company
• 9.2 B. Braun Melsungen AG
• 9.3 Cardinal Health
• 9.4 Coloplast
• 9.5 ConvaTec Inc.
• 9.6 DeRoyal Industries, Inc.
• 9.7 Hollister Incorporated
• 9.8 Integra LifeSciences Corporation
• 9.9 Johnson & Johnson
• 9.10 Klinion
• 9.11 Medline Industries, LP
• 9.12 MIMEDX Group, Inc.
• 9.13 Molnlycke Health Care AB
• 9.14 Safetec of America, Inc.
• 9.15 Smith & Nephew